Preemptive Action: Reducing the Risk of Breast Cancer

Elena Beyzarov, PharmD
Published Online: Thursday, June 14, 2012
Follow Pharmacy_Times:
Pharmacy Times Office of Continuing Professional Education


Preemptive Action: Reducing the Risk of Breast Cancer

Elena Beyzarov, PharmD

Scientific Director Pharmacy Times Office of Continuing Professional Education

Elena Beyzarov, PharmD, has no relevant affiliations or financial relationships with commercial interests to disclose related to this activity

Pharmacy Times Office of Continuing Professional Education Planning Staff

Judy V. Lum, MPA, and Ann C. Lichti, CCMEP have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.

Pharmacy Times Editorial

Bea Riemschneider, Jennifer Barrio, and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity


Educational Objectives

Upon completion of this educational activity, participants should be able to:
  1. Describe the current incidence and prevalence of breast cancer among American women.
  2. Examine factors associated with increased risk of breast cancer, including lifestyle, genetic factors, and hormone replacement therapy.
  3. Examine factors associated with decreased risk of breast cancer, focusing on chemoprevention strategies.
  4. Discuss implications for pharmacists in regard to addressing common patient questions on breast cancer risks and providing evidence-based information on chemoprevention and use of dietary supplements.

Target Audience: Pharmacists

Type of Activity: Knowledge

Release date: June 10, 2012

Expiration date: June 10, 2014

Estimated time to complete activity: 2 hours

Fee: This lesson is free online at www.PharmacyTimes.com. There is a nominal fee of $10.00 for mailed/faxed evaluation and exam forms.

Click here to view this activity



Related Articles
Specialty pharmacy is often considered one of the fastest growing and least understood segments of health care.
Cancer treatment is more closely involving community and specialty pharmacies, as many patients are being treated with oral, subcutaneous, and intravenous (IV) agents in the comfort of their own homes.
As the summer months heat up, Rite Aid is proud to serve as the presenting sponsor of The Skin Cancer Foundation's annual Road to Healthy Skin Tour for the eighth consecutive year.
With the FDA’s approval of Gardasil 9, this vaccine will now be available as a preventive measure against up to 90% of genital, anal, vulvular, and vaginal cancers, thereby offering additional protection for pediatric patients from the human papillomavirus.
Latest Issues
$auto_registration$